Print

Navidea Biopharmaceuticals (NAVB) Announces Board Member Resignation  
7/16/2013 10:07:57 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that Jess Emery Jones, MD, has resigned from his position as a member of Navidea’s Board of Directors for personal reasons, effective July 9, 2013. Dr. Jones has served on the Board of Directors since April 2011. The Company’s Compensation, Nominating and Governance Committee expects to undertake a process in the near future to evaluate Board composition.

Help employers find you! Check out all the jobs and post your resume.

//-->